Intracerebroventricular administration of bacterial lipopolysaccharide prevents the development of acute experimental pancreatitis in the rat by Jaworek, Jolanta et al.
WWW.MEDSCI MONIT.COM
Basic Research
Signature: Med Sci Monit, 2002; 8(4): BR136-143
PMID: 11951059
BR136
Intracerebroventricular administration of bacterial
lipopolysaccharide prevents the development of acute
experimental pancreatitis in the rat
Jolanta Jaworek1 adefg, Joanna Bonior2 bc, Katarzyna Nawrot2 bc, Anna Leja2 bc,
Ryszard Sendur1 bd, Jerzy Stachura3 b, Wiesław Pawlik1 bd, Stanisław Konturek1 adf
1 Chair of Physiology, Collegium Medicum, Jagiellonian University Kraków, Poland
2 Department of Medical Physiology Faculty of Health Care, Collegium Medicum, Jagiellonian University Kraków, Poland
3 Department of Pathomorphology, Collegium Medicum, Jagiellonian University Kraków, Poland
Summary
Background: Lipopolysaccharides (LPS) are responsible for septic shock but low doses of LPS reduce pan-
creatic damage produced by caerulein-induced pancreatitis (CIP) in rats. Leptin, produced by
adipocytes attenuates the severity of CIP. The aim of this study was to evaluate the effect of
intracerebroventricular (i.c.v.) administration of LPS on CIP and plasma leptin level and to
investigate the involvement of sensory nerves (SN) in the effects of LPS on CIP.
Material/Methods: CIP was produced by subcutaneous (s.c.) infusion of caerulein (25 µg/kg) to conscious rats. SN
were deactivated with capsaicin (100 mg/kg s.c.). LPS (0.2, 2, or 20 µg/rat) were applied to the
right cerebral ventricle 30 min prior to CIP.
Results: CIP was manifested by an increase in plasma levels of amylase, lipase, leptin and an anti-
inflammatory interleukin 10 (IL-10), (by 400%, 1000%, 700% and 50%, respectively), con-
firmed by histological examination and accompanied by 40% reduction in pancreatic blood
flow. Pretreatment of CIP rats with i.c.v. LPS resulted in significant reduction of CIP accom-
panied by dose-dependent increase in plasma levels of leptin and IL-10. Deactivation of SN,
which by itself failed to affect CIP, completely reversed the beneficial effects of i.c.v. adminis-
tration of LPS on CIP and reduced plasma leptin and IL-10 concentrations.
Conclusion: Pretreatment with LPS given i.c.v. prevents the development of caerulein-induced pancreati-
tis through the activation of SN and though the release of leptin.
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BACKGROUND
Lipopolysaccharides (LPS, endotoxin) are a component
of the cellular wall of Gram-negative bacteria [1]. They
arouse interest due to their ability to stimulate immune
cells and to activate tissue inflammatory factors [2,3].
Massive release of LPS may lead to septic shock and
multiorgan failure (MOF), and endotoxemia complica-
ting acute pancreatitis is a poor prognostic factor and
may reflect fatal course of this disease [4–7]. Bacterial
endotoxins may also induce pancreatitis by themselves [8].
Recent studies have demonstrated that in contrast to
harmful effects exerted by high concentrations of bacte-
rial LPS, small doses of endotoxins may alleviate inflam-
matory states in the organ. The administration of low-
dose LPS blunted pancreatic injury in the course of
acute experimental pancreatitis in rats, and endotoxins
in trace doses limited the development of acute gastric
ulcers [9–11]. Favorable effects of LPS seems to be asso-
ciated with activation of nitric oxide synthase (NOS) and
increased generation of nitric oxide (NO). Pretreatment
with low dose of LPS improves the blood flow through
the organ, upregulates the cyclooxygenases (COX) and
increased biosynthesis of prostaglandins [10,11].
The protective effects of LPS may also occur through
activation of other less understood mechanisms or intra-
cellular factors such as heat shock proteins which should
increase under the influence of LPS [12]. LPS are able
to release leptin [13–15] and available evidence shows
that leptin has a protective effect on the stomach and
pancreas by modifying the production of cytokines and
activating NO generation and biosynthesis of prosta-
glandins [16–19]. Experimental studies have indicated
that anti-inflammatory effects of leptin are closely corre-
lated with the activation of sensory nerves, because
chemical deactivation of these nerves almost completely
reversed the protective effects of leptin on the stomach
and pancreas [20]. Sensory nerve (SN) fibers are sensi-
tive to neurotoxin capsaicin, which induces reversible
inactivation of these nerves and is used in experimental
studies to identify the role of sensory nerves in the
mechanisms regulating the activity of the digestive sys-
tem [20].
Our previous studies have demonstrated that leptin is
able to protect gastric mucosa and the pancreas against
injury not only following its peripheral administration
but also when it was given by the intracerebroventricu-
lar route [16,17,19,20]. Central administration of such
hormones as dopamine, secretin or CGRP alters the
exocrine function of the pancreas [21–23]. So far no
studies have been performed on the effect of centrally
administered substances that affect leptin release in
acute pancreatitis.
The purpose of our study was: 1. to investigate the
effect of LPS, obtained from Escherichia coli and
applied intracerebroventricularly, on the course of
acute caerulein-induced pancreatitis (CIP) in rats and 2.
to clarify the role of SN and leptin in the central effect
of endotoxin on the pancreas subjected to CIP.
MATERIAL AND METHODS
LPS from Escherichia coli, serotype 0127: BS and cap-
saicin were obtained from Sigma (St. Louis, MO, USA),
caerulein (Takus) from Farmacia GmbH (Erlangen,
Germany).
Wistar rats weighing about 200 g were used. The ani-
mals were kept in cages, fed with standard food and
water ad libitum. Feeding was discontinued 18 hours
prior to the start of the experiments.
The study protocol was approved by the Ethics
Committee on Animal Experiments of the Jagiellonian
University.
Acute caerulein-induced pancreatitis (CIP) was pro-
voked by caerulein in 5-hour subcutaneous (s.c.) infu-
sion at a dose of 5 µg/kg-h. Caerulein was dissolved in
0.9% physiological saline and administered at a rate of 1
ml/h. Control animals were infused with vehicle saline
for 5 h.
LPS at a dose of 0.2, 2 or 20 µg/rat, dissolved in 20 µl of
0.9% saline was given to the right cerebral ventricle
(i.c.v.) as described previously [19, 20]. LPS was applied
as a bolus 30 min before the onset of pancreatitis-induc-
ing infusion of caerulein, or saline in the control tests.
For intracerebroventricular administration of LPS, the
rats were briefly anesthetized with ether. A midline inci-
sion was made on the head exposing the skull and its
sutures. The skull was pierced with a fine sharp needle
at a site 2.5 mm to the sagittal and coronal sutures to
administer LPS or saline. The efficacy of intracere-
broventricular administration of LPS was checked by an
injection of 20 µl of 0.2% toluidine blue.
Each animal group received a different dose of LPS and
the control animals – normal saline. Each control group
consisted of 6–8 animals.
The animals were randomly subdivided into two large
groups. Group I consisted of animals with intact sensory
nerves. Group II consisted of animals in whom sensory
nerves were deactivated with capsaicin. Capsaicin was
applied at a dose of 100 mg/kg s.c. over 3 days, 7 days
prior to study. Both large groups were further subdivid-
ed into subgroups to receive: 1) saline in 5-h s.c. infu-
sion, 2) caerulein at dose of 5 µg/kg-h dissolved in saline
at 5-h s.c. infusion to induce CIP, 3) LPS i.c.v. at a dose
of 0.2 µg/rat followed by a 5-h s.c. infusion of saline,
4) LPS i.c.v. at a dose of 2 µg/rat followed by 5-h s.c.
infusion of saline, 5) LPS i.c.v. at a dose of 20 µg/rat fol-
lowed by a 5-h s.c. infusion of saline, 6) LPS i.c.v. at a
dose of 0.2 µg/rat followed by a 5-h s.c. infusion of
caerulein, 7) LPS i.c.v. at a dose of 2 µg/rat followed by a
5-h s.c. infusion of caerulein, 8) LPS i.c.v. at a dose of
20 µg/rat followed 5-h s.c. infusion of caerulein.
Following 5-h infusion of caerulein, or saline, the ani-
mals were anesthetized with Vetbutal (0.5 ml/kg i.p.),
and then the abdominal cavity was opened. Pancreatic
blood flow was measured by a laser Doppler flowmeter
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using a Laserflo, model BPM 403 A (Blood Perfusion
Monitor, Vasdamedics Inc. St Paul, Mn, USA) as previ-
ously described [10]. Blood flow was measured in five
different pancreatic regions in each rat and expressed
as the percent change of the control value. Immediately
afterwards blood was drawn from the inferior vena cava
for plasma measurement of amylase, lipase, interleukin-
10 (IL-10) and leptin. Plasma amylase was measured
with the modified sacharogenic method using Alpha
Diagnostics kit as described elsewhere [10]. Lipase was
measured using an automatic analyser Kodak Ektachem
with slides (Lipa). Leptin was measured by radioim-
munoassay (RIA) with commercial RIA kit (LINCO
Research Inc. St. Charles, Missouri, USA). Plasma IL-10
was measured with the ELISA method (Enzyme Linked
Immuno-Sorbent Assay) using the kit of Bio-Source
International, Camarillo, California, USA.
The pancreas was then excised, connective and fat tissue
was removed and the pancreas was weighed. Pancreatic
samples were fixed in 10% formalin and then stained
with hematoxylin and eosin for histological study. The
specimen was studied under an optic microscope and
edema, polynuclear cell infiltration and vacuolization
were graded on a scale from 0 to 3 i. e. from absent to
severe lesion.
Figure 1. Effect of increasing doses of LPS, given intracerebroventric-
ularly (i.c.v.) on pancreatic weight in rats with intact or cap-
saicin deactivated sensory nerves subjected to caerulein-
induced pancreatitis. Asterisk indicates a significant
(p<0.05) decrease below the value obtained from rats sub-
jected to caerulein-induced pancreatitis without LPS pretreat-
ment. Means±SEM of 6-8 rats in each experimental group.
Control = rats infused with saline.
Figure 3. Effect of LPS, given intracerebroventricularly (i.c.v.) on plas-
ma lipase level in rats with intact or capsaicin deactivated
sensory nerves subjected to caerulein-induced pancreatitis.
Asterisk indicates a significant (p<0.05) decrease below the
value obtained from rats subjected to caerulein-induced pan-
creatitis without LPS pretreatment. Means±SEM of 6-8 rats
in each experimental group. Control = rats infused with
saline.
Figure 4. Pancreatic blood flow in response to LPS given intracere-
broventricularly (i.c.v.) to rats with caerulein-induced pancre-
atitis with intact or capsaicin deactivated sensory nerves.
Asterisk indicates a significant (p<0.05) decrease below the
value obtained from rats subjected to caerulein-induced pan-
creatitis without LPS pretreatment. Means±SEM of 6-8 rats
in each experimental group. Control = rats infused with
saline.
Figure 2. Effect of LPS, given intracerebroventricularly (i.c.v.) on plas-
ma amylase level in rats with intact or capsaicin deactivated
sensory nerves subjected to caerulein-induced pancreatitis.
Asterisk indicates a significant (p<0.05) decrease below the
value obtained from rats subjected to caerulein-induced pan-
creatitis without LPS pretreatment. Means±SEM of 6-8 rats
in each experimental group. Control = rats infused with
saline.
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Statistical analysis
Analysis of variance and Student's t-test were used to
analyze the results. A p<0.05 was considered as signifi-
cant. The results were expressed as means±SEM
RESULTS
Acute caerulein-induced pancreatitis (CIP) was observed
in all experimental animals, which were given caerulein.
CIP was characterized by an almost double increase in
the pancreatic mass, which is an indicator of pancreatic
edema, a significant increase in plasma levels of amylase
and lipase and in a reduction of pancreatic blood flow to
60% of the control value (Figures 1–5). Histologically,
intralobular and intraalveolar edema, polynuclear cell
infiltration and vacuolization of acinar cells were seen
(Table 1, Fig. 7). Plasma IL-10 in rats with CIP doubled
and leptin increased almost 7-fold as compared to the
control animals without CIP (Fig. 5 and 6).
Administration of LPS to the cerebral ventricles (0.2, 2
or 20 µg/rat) resulted in a significant decrease in the
pancreatic mass (Fig. 1). Histologically, inflammatory
changes were significantly attenuated i. e. edema was
almost completely abolished, and inflammatory infiltra-
tion and vacuolization were markedly diminished
(Table 1, Fig. 7).
Plasma levels of amylase and lipase were dramatically
decreased in CIP rats pretreated with i.c.v. LPS (Figs 2
and 3). Pancreatic blood flow in CIP rats receiving LPS
intracerebroventricularly was increased in a dose-
dependent manner, achieving almost 100% of the con-
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Edema 
(0-3)
Neutrophile
infiltration (0-3)
Vacuolization
(0-3)
Control
Caerulein-induced
pancreatitis (CIP)
Caerulein-induced pancreatitis
+ LPS i.c.v. 0.2 mg/rat
Caerulein-induced pancreatitis
+ LPS i.c.v. 2 mg/rat 
Caerulein-induced pancreatitis
+ LPS i.c.v. 20 mg/rat
LPS i.c.v. 0.2 mg/rat
LPS i.c.v. 2 mg/rat
LPS i.c.v. 20 mg/rat
0
2.2±0.05
1.6±0.2
1.0±0.1*
0.6±0.05*
0.2±0.1
0.2±0.05
0
0
2.0±0.2
1.8±0.1
0.86±0.2*
0.7±0.2*
0
0
0
0
2.6±0.1
1.6±0.2
1.1±0.1“
1.0±0.05*
0
0
0
Table 1. Histological changes induced by caerulein-induced pancreati-
tis (CIP) alone, intracerebroventricular administration of LPS
(0.2, 2, or 20 mg/rat) alone, or combination of above in rats
with intact sensory nerves. Asterisk indicates a significant
change as compared with CIP alone.
Edema
(0-3)
Neutrophile
infiltration (0-3)
Vacuolization
(0-3)
Control INC
Caerulein-induced
pancreatitis - INC.
Caerulein-induced pancreatitis
+ LPS i.c.v. 0.2 mg/rat INC
Caerulein-induced pancreatitis
+ LPS i.c.v. 2 mg/rat INC
Caerulein-induced pancreatitis
+ LPS i.c.v. 20 mg/rat INC
LPS i.c.v. 0.2 mg/rat INC
LPS i.c.v. 2 mg/rat INC
LPS i.c.v. 20 mg/rat INC
0
2.5±0.1
2.3±0.2
2.50±0.1
2.1±0.1*
0.2±0.1
0.1±0.05
0
0
2.0±0.2
2.0±0.1
2.2±0.4
1.8±0.2
0
0
0
0
2.1±0.1
1.8±0.3
2.2±0.1
2.0±0.1
0
0
0
Table 2. Histological changes induced by caerulein-induced pancreatitis
(CIP) alone,intracerebroventricular administration of LPS (0.2,
2, or 20 mg/rat) alone, or combination of above in the rats with
sensory nerves deactivated with capsaicin (INC). Asterisk indi-
cates significant change as compared with CIP alone.
Figure 5. Effect of LPS given intracerebroventricularly on leptin plasma
level in rats with caerulein-induced pancreatitis with intact or
capsaicin deactivated sensory nerves. Asterisk indicates a
significant (p<0.05) decrease below the value obtained from
rats subjected to caerulein-induced pancreatitis without LPS
pretreatment. Means±SEM of 6–8 rats in each experimental
group. Control = rats infused with saline.
Figure 6. Plasma IL-10 in response to LPS given intracerebroventricu-
larly (i.c.v.) to rats with caerulein-induced pancreatitis with
intact or capsaicin deactivated sensory nerves. Asterisk indi-
cates a significant (p<0.05) decrease below the value
obtained from rats subjected to caerulein-induced pancreati-
tis without LPS pretreatment. Means±SEM of 6-8 rats in
each experimental group. Control = rats infused with saline.
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trol value at a dose of 20 µg/rat (Fig. 4). Anti-inflamma-
tory IL-10 in CIP rats pretreated with LPS increased
markedly as compared to the level obtained in CIP ani-
mals without LPS. Intracerebroventricular administra-
tion of LPS at a dose of 2 µg/rat to the CIP rats resulted
in double increase of plasma level of IL-10, and follow-
ing i.c.v. pretreatment of CIP rats with LPS at dose of
20 µg/rat plasma level of this interleukin increased more
than 3-fold as compared to IL-10 level obtained in ani-
mals subjected to CIP alone (Fig. 5).
Plasma leptin level in rats pretreated with LPS given
i.c.v. with subsequent CIP was further increased as com-
pared to the animals with CIP alone (Fig. 6).
Administration of LPS i.c.v. at a dose of 20 µg/rat dou-
bled plasma leptin level as compared to CIP animals
without LPS pretreatment (Fig. 6).
In rats with sensory nerves deactivated with capsaicin,
administration of caerulein (5 µg/kg-h x 5 h) to induce
CIP, did not produce significant differences in edema
severity, morphology of pancreatic tissue, pancreatic
blood flow or plasma amylase or lipase, as compared to
CIP animals with intact sensory nerves (Figs 1–8, table 2).
Figure 7. Histological section of pancreas from intact rats (A-1),
severe edema, infiltration and cell vacuolization in the pan-
creas of rats subjected to caerulein-induced pancreatitis 
(B-1), and mild inflammatory changes represented by
reduced edema and neutrophil infiltration in the pancreas of
rats with CIP pretreated with LPS (20 µg/rat i.c.v.) (C-1).
Hematoxylin-eosin stain, magnification 165x.
Figure 8. Deactivation of sensory nerves with capsaicin failed to affect
the histological appearance of pancreas (A-2), severe
edema, infiltration and cell vacuolization in the pancreas of
capsaicin-pretreated rats subjected to caerulein-induced
pancreatitis (B-2), intracerebroventricular administration of
LPS (20 µg/rat i.c.v.) failed to affect significantly the inflam-
matory changes produced by caerulein-induced pancreatitis
in the pancreas of rats with capsaicin-deactivated sensory
nerves (20 µg/rat i.c.v.) (C-2). Hematoxylin-eosin stain.
Magnification 165 x.
A–1 A–2
B–2
C–2C–1
B–1
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Inactivation of sensory nerves by capsaicin resulted in
complete abolition of the protective effects of LPS (0.2, 2
or 20 µg/rat i.c.v.) on the pancreas of CIP rats (Figs 1-6,
8 Table 2). In these animals marked pancreatic edema,
high plasma levels of amylase and lipase and reduced
pancreatic blood flow were observed (Figs 1-3). Above
reversion of the favorable effect of LPS on the pancreas
of CIP rats with inactivated sensory nerves was con-
firmed by histological examination of the pancreatic tis-
sue (Table 2, Fig. 8).
In the rats with capsaicin-deactivated sensory nerves
subjected to CIP plasma level of IL-10 was reduced, as
compared to the plasma level of this interleukin
observed in the CIP rats with intact sensory nerves.
Central administration of LPS to the CIP rats with sen-
sory nerves deactivated with capsaicin failed to affect
significantly this low plasma level of IL-10 (Fig. 6).
Deactivation of sensory nerves caused an abrupt fall of
plasma leptin in CIP animals as compared to the level
measured in CIP animals with intact sensory nerves.
LPS administration to above animals did not produce
any significant alteration of plasma leptin levels (Fig. 7).
DISCUSSION
In this study we investigated whether bacterial LPS
applied centrally may affect the course of acute pancre-
atitis induced by overstimulation of the pancreas with
caerulein and if so by what could be the mechanism of
this effect. .
It was previously demonstrated that cerebral centers
play an important role in the regulation of exocrine
pancreatic secretion [21,22,24]. Dorsal vagal complex
(DVC) has been recently identified as the main center
responsible for the control of pancreatic enzymes secre-
tion though activation of sympathetic nerves and adre-
nal gland [25]. However, no reports have been pub-
lished concerning the involvement of brain centers in
the modulation of the inflammatory processes in the
pancreas.
Our study clearly demonstrates that LPS from
Escherichia coli applied centrally to CIP rats are able to
produce almost complete reversion of inflammatory
changes produced by caerulein overstimulation in the
pancreas of CIP rats. In CIP rats pretreated intracere-
broventricularly with LPS significant reduction of pan-
creatic edema, decreased plasma levels of lipase and
amylase and normalization of pancreatic blood flow,
which was formerly limited by acute inflammation, was
observed. The effect of LPS reducing the development
of acute pancreatitis largely depends on the activation of
sensory nerves, because deactivation of these nerves by
capsaicin completely abolished favorable effects of LPS
on the pancreas. It has been hypothesized that these
sensory nerves originating in the pancreas transmit
impulses to vagal centers in medulla and then act on the
pancreas through efferent autonomic nerves and vari-
ous neuromediators such as leptin, CGRP, VIP etc.
Previous reports, including those from our laboratory,
have demonstrated that intraperitoneal administration
of small doses of bacterial endotoxins from Escherichia
coli prior to acute pancreatitis activated immune mecha-
nisms and reduced pancreatic tissue injury [9,10].
Favorable effects of LPS, alleviating acute pancreatitis
are mainly associated with increased generation of nitric
oxide (NO), whereas high doses of LPS given to experi-
mental animals aggravate the inflammatory process in
the pancreas [8,10,26].
Acute pancreatitis activates a variety of pathogenic
mechanisms by which pancreatic injury occurs, such as
the generation of reactive oxygen and nitrogen species,
reduction in pancreatic blood flow, accumulation of
pro-inflammatory cytokines [5,27–30]. In parallel with
injury factors immune mechanisms are mobilized, which
include increased generation of NO, endogenous
prostaglandins or antioxidants, which act to reduce the
inflammatory state and tissue injury [3,28,31]. The
severity of acute pancreatitis depends on injury factor,
occurring in the course of inflammation and on the
mobilization of immune mechanisms. The latter are a
subject of extensive experimental and clinical studies,
but until now it is not known which factors play a key
role in pancreatic protection.
Present findings have indicated that pancreatoprotec-
tive effect of centrally applied LPS is associated with the
release of leptin and depends on the activation of senso-
ry nerves. Leptin is produced in adipose cells and peri-
toneal organs, such as the stomach and pancreas, and is
known to regulate food intake and energy expenditure
[32] However, recent studies have indicated that plasma
leptin levels could be markedly stimulated by bacterial
endotoxins [13–15]. A significant increase of leptin
release have been observed in the early stage of inflam-
mation [33, 35]. Numerous studies have indicated that
leptin is involved in the modulation of immune
response of the organism through activation of
macrophages, effect on lymphocytes and cytokines
[18,23,36–38]. Because of the contribution of leptin to
the inflammatory process and similarity between the
structure of leptin receptor and interleukin receptor
(IL-6, IL-11, GCSF) leptin is classified as a cytokine [34].
As shown in our previous studies leptin is able to protect
the pancreas against the injury caused by acute inflam-
mation [17,20]. Above beneficial effects of leptin are
mediated by sensory nerves [20]. Because of the pres-
ence of leptin receptors on pancreatic neurons leptin
was though to be involved in the modulation of signals
transmission in pancreatic nerves acting as a neuromod-
ulator [39]. The observation that leptin could affect the
synaptic activity of pancreatic neurons supports this
notion [40].
Recent studies have demonstrated that pancreatopro-
tective effect of leptin is also associated with increased
generation of NO. It was found that leptin released
locally in the pancreas could affect gene expression of
constitutional nitric oxide synthase and could stimulate
NO release from pancreatic acini [18,20,]. This NO of
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pancreatic origin, by penetrating the surrounding tis-
sues, may lead to the relaxation of blood vessels. This
improves the haemodynamic conditions in the inflam-
matory pancreas and limit the pancreatic tissue injury.
Recent studies have demonstrated that leptin could pro-
duce relaxation of blood vessels on different ways, and
its vasoactive effect depends on the increased genera-
tion of NO, as well as on the others, yet undefined,
mechanisms independent on nitric oxide [41,42].
Acute pancreatitis leads to the activation of inflammato-
ry cells, macrophages and lymphocytes and to increased
release of cytokines involved in the regulation of
immune responses [5,43]. Blood level of pro-inflamma-
tory cytokines increases (IL-1, IL-6, IL-8, TNFα) with
simultaneous decrease in anti-inflammatory interleukins
such as IL-4 or IL-10 [27,43,44]. Our recent studies on
pancreatoprotective effects of leptin have demonstrated
that leptin could modify the cytokine production in
acute pancreatitis, leading to the decrease of pro-inflam-
matory TNFα, with concomitant rise of anti-inflamma-
tory IL-4 in the plasma [17]. In the present study we
analyzed the relationship between central administra-
tion of LPS and blood levels of leptin and anti-inflam-
matory IL-10. Previous studies have demonstrated that
anti-inflammatory IL-10 is able to inhibit the produc-
tion of pro-inflammatory cytokines such as TNFα, IL-6
or IL-8 [45]. According to the recent findings, IL-10
could attenuate the course of pancreatitis or prevents
the pancreas from acute inflammation [5,31]. In present
study we found a close correlation between leptin
release by LPS and an increase in plasma level of IL-10.
Inactivation of sensory nerves by capsaicin leads to com-
plete reversal of favorable effects of LPS on the pancreas
and it also decreases blood leptin levels.
Studies on the role of leptin in the digestive system have
demonstrated that endogenous leptin may be produced
in the gastric mucosa and in the pancreas [16,18,46].
Administration of exogenous leptin protects gastric
mucosa against acute lesion through a mechanism asso-
ciated with the activation of arginine-NO system and
stimulation of CCK release [16]. It has been shown that
low dose of bacterial LPS exerts gastroprotective and
pancreatoprotective effects leading to increased genera-
tion of NO [10,11]. These beneficial effects of LPS on
the pancreas resembles those exerted by leptin [17,18].
However, the relationship between central administra-
tion of LPS, leptin release and pancreatic protection has
not been studied until now.
CONCLUSIONS
The present study demonstrates that administration of
LPS by the intracerebroventricular route limits the
development of acute pancreatitis and reduces pancre-
atic injury. The alleviation of pancreatitis by LPS is
accompanied by increased blood level of anti-inflamma-
tory IL-10 and this effect may be mediated by the acti-
vation of sensory nerves and release of leptin by LPS.
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